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Abstract
Mitochondria-ER contact sites (MERCS) are known to underpin many important cellular homoeostatic functions, including
mitochondrial quality control, lipid metabolism, calcium homoeostasis, the unfolded protein response and ER stress. These
functions are known to be dysregulated in neurodegenerative diseases, including Parkinson’s disease (PD), Alzheimer’s
disease (AD) and amyloid lateral sclerosis (ALS), and the number of disease-related proteins and genes being associated
with MERCS is increasing. However, many details regarding MERCS and their role in neurodegenerative diseases remain
unknown. In this review, we aim to summarise the current knowledge regarding the structure and function of MERCS, and
to update the field on current research in PD, AD and ALS. Furthermore, we will evaluate high-throughput screening
techniques, including RNAi vs CRISPR/Cas9, pooled vs arrayed formats and how these could be combined with current
techniques to visualise MERCS. We will consider the advantages and disadvantages of each technique and how it can be
utilised to uncover novel protein pathways involved in MERCS dysfunction in neurodegenerative diseases.
Facts
● Mitochondria can form contacts with the ER to regulate
vital cellular homoeostatic functions.
● A range of mitochondria-ER contact site (MERCS)
tethering proteins maintain these contacts and facilitate
their functions. Inositol 1,4,5-triphosphate receptor
(IP3R), voltage-dependent anion channel (VDAC),
glucose-related protein 75 (GRP75) and deglycase
(DJ-1) act as a tetramer to regulate Ca2+ homoeostasis.
Mitofusin-2 (MFN2) and mitofusin-1 (MFN1) can act as
a physical tether, control Ca2+ homoeostasis and
regulate mitochondrial morphology changes. Vesicle-
associated membrane protein B (VAPB) and protein
tyrosine phosphatase-interacting protein-51 (PTPIP51)
are physical tethers and can impact Ca2+ homoeostasis,
while B-cell receptor-associated protein-31 (BAP-31)
can regulate apoptosis.
● MERCS are dysfunctional in neurodegenerative dis-
eases, including Alzheimer’s disease (AD), Parkinson’s
disease (PD) and amyloid lateral sclerosis (ALS).
● Pooled or arrayed high-throughput screening can be
used in conjunction with CRISPR/Cas9 or RNAi to
identify novel disease-relevant pathways in many
neurodegenerative diseases.
● The gold standard for visualising MERCS is electron
microscopy and super-resolution techniques, but these
require vast quantities of sample or image processing
and so are not suitable for high-throughput screening.
● A range of split fluorescent protein constructs have been
developed, which can be used to visualise MERCS in
real time, and are suitable for high-throughput screening.
Open questions
● What are the molecular mechanisms that govern
MERCS dysfunction in neurodegenerative diseases such
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as AD, PD and ALS? Is there an overarching disease
mechanism related to MERCS?
● How can electron microscopy, super resolution, split FP
techniques and Ca2+ indicators be adapted and opti-
mised for high-throughput screening and which of them
will provide the most accurate and efficient readout?
Introduction
For many years, the textbook view of organelles has been
that they function independently and in isolation from
each other, forming separate contained entities within a
cell. Now, however, contacts between organelles are
shown to play fundamental roles in many aspects of cel-
lular health. Membrane contact sites are sections of two
adjacent membranes that are in close proximity, but do not
fuse. They provide ‘hotspots’ for lipid and ion transfer, as
well as signalling and cross talk between organelles. One
of the most well-studied membrane contact sites is the
mitochondria-ER contact site (MERCS). MERCS was
originally identified by electron microscopy (EM) of rat
tissue in the 1950s [1], and typically has a diameter of
10–80 nm. The diameter of MERCS can fundamentally
affect its functions, which include lipid metabolism, cal-
cium (Ca2+) homoeostasis, unfolded protein response
(UPR), ER stress and mitochondrial quality control
(MQC), all of which have been implicated in neurode-
generative diseases such as Alzheimer’s disease (AD),
Parkinson’s disease (PD) and amyotrophic lateral scoliosis
(ALS) [2]. However, much work is still needed to eluci-
date how MERCS affects the progression of neurodegen-
eration [3].
This review aims to update the field on the molecular
composition and functions of MERCS, with specific focus
on its impact in AD, PD and ALS. We will then discuss
techniques used to study MERCS and evaluate their suit-
ability in high-throughput screening (HTS) to identify novel
protein targets involved in MERCS regulation and neuro-
degenerative diseases.
The molecular basis of ER-mitochondria
contact sites
EM shows small black rods reaching between the ER and
mitochondrial membrane, these were found to be molecular
bridges pinning the two membranes together. These mole-
cular bridges are composed of tethering proteins, and stu-
dies have shown a huge variety of molecular tethers,
ranging from Ca2+ channels to apoptotic proteins [4]
(Fig. 1).
IP3R–DJ-1–GRP75–VDAC
The first tethering complex identified was between the
voltage-dependent anion channel (VDAC) (an outer
mitochondrial membrane (OMM) protein) and the ER-
residing inositol 1,4,5-triphosphate receptor (IP3R). This
interaction is regulated by glucose-related protein 75
(GRP75) (a molecular chaperone) and deglycase (DJ-1), a
protein mutated in PD, that has been revealed to interact
with VDAC, IP3R and GRP75 [5, 6]. Together, IP3R,
VDAC, GRP75 and DJ-1 act as a tetramer complex to
regulate the transfer of Ca2+ from the ER to the mito-
chondrial matrix via the mitochondrial calcium uniporter
(MCU). Interestingly, complete loss of IP3R did not show
a physical alteration in MERCS; however, the loss of
GRP75 or DJ-1 abolishes the Ca2+ influx into the mito-
chondria [5–7] suggesting that the tetramer of VDAC,
Fig. 1 The molecular composition of mitochondria-ER contact
sites: several sets of complexes tether the mitochondria and ER.
BAP-31 in the ER interacts with Fis-1 and TOMM40 in the OMM.
PACS-2, a multifunctional sorting protein in the ER, regulates BAP-31
MERCS interactions. IP3R in the ER and VDAC in the OMM form a
tetramer complex with regulatory proteins, GRP75 and DJ-1, to con-
trol calcium (Ca2+) transfer into the mitochondria. Further regulatory
proteins such as TG2 and PDK-4 also bind GRP75–IP3R–VDAC
complex regulating MERCS. Sig-1R accumulates in MERCS and can
stabilise IP3R in MERCS, but also interacts with chaperone protein
BIP in the ER lumen. ATAD3A can cross the IMM and OMM to
interact with BiP in the ER via the cytosolic protein WASF3 and other
unknown proteins. MFN2 is located in both the ER and mitochondrial
membrane and can homodimerise with itself or heterodimerise with
MFN1 in the OMM. MFN2 has known interactions with PERK, which
are required for progression through the UPR. Finally, VAPB in the
ER membrane and PTPIP51 in the OMM interact and directly regulate
MERCS size and length and act as a physical tether.
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IP3R, GRP75 and DJ-1 acts as a functional tether, rather
than a physical one [4].
Mitofusins
Mitofusin-2 (MFN2) is one of the most well-studied, yet
most controversial, MERCS tethers. MFN2 is known for its
role in mitochondrial fusion; however, it also localises at
ER membranes and can hetero- or homodimerise with
mitofusin-1 (MFN1) or MFN2 in the OMM. The Scorrano
group first described MFN2 as a physical tether between the
ER and mitochondria; however, these results have been
called into question owing to the analysis methods used [8].
Other groups have shown that knockdown of MFN2 results
in an increase in MERCS, with accompanying increases in
Ca2+ transfer, supporting the notion that MFN2 is not a
physical tether [9, 10]. Most recently, however, the Scor-
rano group provided new evidence, using split fluorescent
protein (FP) systems, to demonstrate that loss of MFN2
causes a decrease in the distance between ER and mito-
chondria membranes, impairing Ca2+ uptake into the
mitochondria [11]. Overall, it is accepted that MFN2 is a
key component of MERCS and is important in the appro-
priate functioning of MERCS.
VAPB and PTPIP51
Vesicle-associated membrane protein B (VAPB) is an ER-
residing protein that interacts with protein tyrosine
phosphatase-interacting protein-51 (PTPIP51) in the OMM
[12]. EM and confocal microscopy show that alterations in
PTPIP51 or VAPB are accompanied by changes in the
proportion of ER in contact with the mitochondria; thus,
loss of these proteins can decrease MERCS [13]. The
interactions between VAPB and PTPIP51 directly affect the
function of MERCS, as depletion of either can disturb Ca2+
handling, resulting in a delay in Ca2+ uptake by the mito-
chondria. Furthermore, a VAPB mutant, which decreases
Ca2+ handling, also shows aggregation of the mitochondria
[12–14]. Together, these data suggest that MERCS impacts
on the health of the mitochondria, and this can be regulated
by the VAPB–PTPIP51 tether complex
BAP-31
B-cell receptor-associated protein-31 (BAP-31) is a 28-kDa,
ER-residing, membrane chaperone that can physically
interact with mitochondrial fission protein-1, serving as a
platform to promote recruitment and activation of procas-
pase 8 and the transmission of pro-apoptotic signals from
the mitochondria to the ER. This interaction is also present
in non-apoptotic cells suggesting that it forms a preformed
scaffold complex [15, 16]. In addition, loss of phosphofurin
acidic cluster sorting protein-2 (PACS-2), which can reg-
ulate the ER-mitochondria axis, results in BAP-31- medi-
ated fragmentation of the mitochondria, depletion of Ca2+
signal and a decrease in MERCS itself [17]. Furthermore,
BAP-31 has been shown to regulate mitochondrial oxygen
consumption, autophagy and maintain mitochondrial
homoeostasis through interactions with TOMM40, mito-
chondrial respiratory chain complexes and NADH: ubiqui-
none oxidoreductase (mitochondrial complex 1) core
subunit 4 (NDUFS4) located in MERCS [18]. These data
suggest that BAP-31 can act as a MERCS tether and a
platform for transmittance of apoptotic signals between ER
and mitochondria.
Other MERCS regulatory proteins and tethering
components
In addition to the previously discussed protein tethers,
MERCS has a wide range of regulatory proteins. Of note
are transglutaminase 2 (TG2), sigma 1 R (Sig-1R), pyruvate
dehydrogenase kinase-4 (PDK-4) and ATPase family AAA
domain-containing protein-3 (ATAD3A). TG2 interacts
with GRP75 regulating MERC number, Ca2+ flux and
protein composition [19]. Sig-1R (a ligand- operated cha-
perone), accumulates at MERCS and promotes the stabili-
sation of IP3R, prolonging Ca
2+ signalling into the
mitochondria [20, 21]. In skeletal muscle, further levels of
regulation are achieved via PDK-4, which interacts with
GRP75–IP3R–VDAC complex at MERCS, and is required
for mitochondrial-associated membrane (MAM) formation
[21]. Finally, ATAD3A, an AAA+ATPase located to the
inner mitochondrial membrane (IMM) and also enriched in
MERCS, can interact with OMM and ER-resident proteins,
including MFN2, Drp1 and BiP via the cytosolic protein
WASF3 [22, 23]. ATAD3A has roles in hormone-
dependent MERCS increase and mitochondrial dynamics
[23–26]. Regulatory proteins allow sophisticated control
over the size, dimeter and homoeostatic functions of
MERCS allowing for highly dynamic responses.
Functions of ER-mitochondria contact sites
The molecular make-up of MERCS can greatly affect its
function, with specific tethers acting on specific functions,
including lipid metabolism, Ca2+ homoeostasis, MQC as
well as ER stress and the UPR. These functions are crucial
in cellular survival and proliferation (Fig. 2).
Lipid transfer
MERCS is key to several lipid metabolism pathways and is
required for the transfer of lipids from the ER to the
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mitochondria and back again. The main lipid metabolism
pathway starts when ER- produced phosphatidic acid (PA) is
converted by phosphatidylserine synthase (Pss1/2) to phos-
phatidylserine (PS) in the ER. To form other phospholipids
such as phosphatidylethanolamine (PE), PS is shuttled from
the ER to the mitochondrial inner membrane space via
MERCS, where it is decarboxylated by PS decarboxylase
(PSD) to PE. This can then be further modified in the ER by
Fig. 2 Cellular functions of mitochondria-ER contact sites. a Lipid
metabolism requires the transfer of phospholipids from the ER to
mitochondria and back again at MERCS. Phosphatidylserine (PS) in
the ER is transferred to mitochondria where it is converted to phos-
phatidylethanolamine (PE) by enzyme PS Decarboxylase (PSD). PE is
shuttled back to ER where PE-N-methyltransferase (PEMT) modifies
it to phosphatidylcholine (PC). b Ca2+ homoeostasis underpins many
MERCS functions and is essential to maintain cellular health. The
tetramer complex IP3R, VDAC, GRP75 and DJ-1 allow transfer of
Ca2+ from ER through IP3R and VDAC to the inter mitochondria
membrane space, producing Ca2+ hotspots. These hotspots activate
MCU, allowing Ca2+ into the mitochondria matrix that promotes
enzymes involved in ATP production, such as PHD, IDH and OGDH.
c MERCS impacts on MQC pathways. Both mitochondria fission and
fusion require the ER and occur at MERCS. Mitochondrial fusion
allows the mixing of damaged and healthy mitochondria components,
diluting the damage and helping to maintain the overall health of the
mitochondria. Mitochondrial fission can protect the mitochondria
network by segregating highly damaged sections, promoting
mitophagy. Mitochondrial fission genes Drp1 and Fis-1 and mito-
chondrial fusion genes, MFN1/2 and OPA1 regulate changes in
mitochondrial morphology. MFN2 is found in MERCS, and it is
established that the ER constricts the mitochondria, allowing oligo-
merisation of Drp1 around the mitochondria. MERCS is also involved
in mitophagy; both PINK1 and Parkin are found in MERCS under
mitophagy induction, as well as key autophagy components ATG5 and
ATG14L. d The accumulation of unfolded proteins in the ER increases
ER stress and upregulates the chaperone protein BIP that initiates the
UPR. BiP activates three pathways of the UPR: ATF6, IRE3 and
PERK. Activation of these receptors activates chaperone proteins,
antioxidant response proteins and ER-associated protein degradation
(ERAD) machinery. ER stress can increase Ca2+ import into the
mitochondria to increase the efficiency of Ca2+-dependent enzymes
PDH, IDH and IGDH required in ATP production, providing energy
for the chaperone machinery. A balance is required, however, as high
Ca2+ influx into mitochondria, caused by severe ER stress, can trigger
mitochondria permeability transition pore (mPTP) opening, leading to
mitochondrial swelling and the initiation of apoptosis.
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PE-N-methyltransferase (PEMT) to phosphatidylcholine
(PC). As PSD is only found in the mitochondria, MERCS is
extremely important in the production of PE, which con-
stitutes a large proportion of the membranes within the cell
[27]. The transfer of PS from the ER to the mitochondria via
MERCS is the rate-limiting step in this lipid biogenesis
pathway, and thus is vital to the maintenance of the cellular
and mitochondrial phospholipid balance [28].
MERCS is also involved in the metabolism of other
lipids, including cholesterol. Mass spectrometry revealed
that Caveolin-1, a protein involved in cholesterol distribu-
tion and organisation, is the main component of MAM
fractions. Furthermore, MERCS has a higher percentage of
cholesterol and sphingolipids compared with bulk ER
membranes, helping to stabilise the membranes [29–31].
Thus, lipid metabolism is a key function of MERCS and
important in overall cell health.
Calcium homoeostasis
Ca2+ is an important second messenger in many cellular
pathways. Ca2+ signalling relies on a low cytosolic Ca2+
concentration ([Ca2+]), which can be achieved through entry
of Ca2+ into the mitochondria via MERCS. It has been
proposed that Ca2+ exits the ER via IP3R and enters the
mitochondria through VDAC, producing a Ca2+ hotspot [32].
This hotspot is one order of magnitude greater than cytosolic
[Ca2+], allowing the threshold for fast Ca2+ transfer into the
mitochondria matrix via the highly selective low-affinity
Ca2+ channel MCU in the IMM [33, 34]. This is important as
enzymes such as isocitrate dehydrogenase and oxoglutarate
dehydrogenase (required in Krebs cycle) and pyruvate
dehydrogenase (required in glycolysis) are situated in the
mitochondria matrix and are Ca2+-dependent [35]. Perturbing
Ca2+ shuttling through MERCS can decrease ATP produc-
tion and the oxygen consumption rate [36, 37]. However, a
fine balance of Ca2+ entry into the mitochondria is required,
as elevated mitochondria matrix Ca2+ can result in increased
mitochondria membrane permeability and damage to the
mitochondria itself. This process is mediated by the mito-
chondrial permeability transition pore (mPTP), a non-specific
high-conductance, voltage- dependent channel. The activa-
tion of this channel causes the mitochondrial membrane to
become permeable to proteins of up to 1,500 Da, causing
swelling and OMM rupture, allowing the release of pro-
apoptotic factors from the mitochondria, uncoupling of oxi-
dative phosphorylation and increased reactive oxygen species
(ROS) [38, 39].
Mitochondria quality control
There are a range of MQC mechanisms that protect against
mitochondrial insult. These include the regulation of
mitochondria morphology, mitochondria microtubule
dynamics and mitophagy [40]. An early MQC mechanism
is the regulation of mitochondria morphology via pro-fusion
and pro-fission proteins. Mitochondrial fission occurs at
MERCS and is facilitated by the ER enveloping the mito-
chondria, and thus constricting it [41]. This constriction
allows the oligomerised dynamin- related protein-1 (Drp1),
a pro-fission protein, to translocate to the mitochondria,
enabling further constriction by Dynamin 2 and fission of
the mitochondrial network [41]. Furthermore, both MFN2
and MFN1 are pro-fusion proteins and key MERCS
tethering proteins, suggesting a strong link between the two
[8–11]. It has recently been reported that fusion machinery,
including MFN2, converges at MERCS aiding mitochon-
dria fusion at these sites [42]. These data demonstrate that
MERCS is a key location for both fission and fusion of the
mitochondria network and is intrinsically linked to MQC.
Mitophagy, the bulk degradation of mitochondria, is also
linked to MERCS. Pre-autophagosome markers ATG14L
and ATG5, key autophagy components, are localised to
MERCS upon starvation- induced mitophagy [43]. Studies
in yeast also found that efficient mitophagy depends on
MERCS tethers, and that the yeast tether, ERMES, co-
localises with the sites of autophagosome biogenesis [44].
In accordance with this, the flux of Ca2+ from the ER to the
mitochondria through MERCS is required for both starva-
tion and PINK1/Parkin-induced mitophagy [45]. Further
studies have revealed that the mitophagy machinery
uncouples the mitochondria from the ER via destruction of
MFN2, which is an early target of PINK1/Parkin-mediated
phosphoubiquitination, facilitating mitophagy [46]. This
demonstrates that uncoupling and coupling of ER and
mitochondria membranes are both required for efficient
mitophagy, and that MERCS has a key role in maintaining
efficient MQC mechanisms and mitochondrial health.
ER stress and unfolded protein response (UPR)
MERCS has also been connected with ER stress and UPR,
an intracellular signalling pathway that is activated by the
accumulation of unfolded proteins in the ER [47]. Under
basal conditions, ER- residing chaperone proteins, includ-
ing BiP, hold proteins in the ER, allowing them to fold
correctly. An accumulation of unfolded proteins can result
in ER stress that is detected by BiP and initiates the UPR
[48]. The UPR is predominantly composed of 3 major
pathways: PERK, IRE1 and ATF6. Once activated, they
allow the upregulation of chaperone proteins and prevent
further translation of proteins. ER stress has been shown to
increase Ca2v uptake into the mitochondria, increasing ATP
production and providing energy for the chaperone
machinery to aid in the folding of proteins, thereby pre-
venting ER stress and apoptosis [49]. These initial
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responses to ER stress have been reported to be accom-
panied by an increase in MERCS [50]; however, when the
ER stress becomes too severe, apoptosis can also be
induced through mPTP and MERCS [51]. Interestingly, two
downstream pathways of the UPR have been associated
with MERCS. Firstly, PERK has been shown to directly
interact with MFN2, this interaction being required for the
progression into the UPR [52], with PERK silencing indi-
cating weakened MERCS and protection against ROS
damage [53]. More recently, IRE1α was discovered as a
novel substrate for MITOL, an OMM E3 ubiquitin ligase
that can regulate MERCS [54]. MITOL can block IRE1α-
mediated mRNA decay and MITOL loss enhances IRE1α-
dependent apoptosis in a MERCS-dependent manner [55].
These studies suggest that MERCS and the UPR are closely
linked, and that MERCS can regulate the health of ER,
however, their exact role is still under investigation.
ER-mitochondria contact sites in
neurodegeneration
Alzheimer’s disease
AD studies were among the first to demonstrate a link
between neurodegeneration and MERCS. The key pathologic
hallmarks of AD are aberrant protein aggregates of hyper-
phosphorylated Tau and extracellular plaques of β-amyloid
(Aβ). Aβ40 and Aβ42 are the main component of extra-
cellular plaques and are the result of abnormal cleavage of
amyloid precursor protein (APP) by Presenilin 1 (PS1) and
Presenilin 2 (PS2), active components of the γ-secretase
complex. APP and PS1/2 are the principal genes associated
with familial AD [56]. PS1 and PS2 are enriched at MAMs
correlating with an increase in γ-secretase activity [57]. In
addition, APP and β-secretase are also localised and pro-
cessed at MERCS [58, 59]. Mutations in PS1, PS2 or APP
result in increased MERCS proximity and enhanced lipid
metabolism [60, 61]. In vitro and in vivo models of AD have
also been investigated for alterations in MERCS, but the
impact in AD is still disputed. Exposure of oligomeric Aβ in
primary hippocampal neurones increases MERCS and alters
Ca2v homoeostasis [62], while familial or sporadic AD patient
fibroblasts have increased ER-mitochondria coupling and
MERCS function, including phospholipid and cholesterol
metabolism [61]. However, dynamic and ultrastructural ana-
lysis of hippocampal neurones from AD rat models showed a
decrease in MERCS, correlating with a reduction in lipid
metabolism and specific alterations in mitochondria lipids
[63]. In Drosophila, forced expression of an artificial linker,
that increases MERCS in vivo, rescues locomotion and pro-
longs the survival of AD models [64]. Studies of AD mice
have shown changes in the proteasome occurring in MERCS
in the early stages of amyloid accumulation that predate
symptoms of AD, such as memory loss [65]. This leads to the
hypothesis that MERCS dysregulation may impact the pro-
gression of AD. This is plausible as many functions of
MERCS are prerequisites for neurodegeneration. Overall,
however, many of these results remain contradictory
(Fig. 3a).
Parkinson’s disease
There is growing evidence that MERCS also plays an
important role in PD pathogenesis. Firstly, α-Synuclein, the
most common component of Lewy bodies, a hallmark of
PD, can localise to MERCS, with WT α-Synuclein asso-
ciating more with MERCS than PD-related mutations [66];
however, how α-Synuclein influences MERCS is disputed.
α-Synuclein has been reported to interact with VAPB, with
overexpression of α-Synuclein WT, A30P or A53T causing
a decrease in VAPB and PTPIP51 binding correlating with
a reduction in MERCS, Ca2+ flux and ATP production [67].
Others have reported that α-Synuclein and its pathogenic
mutations enhance MERCS and Ca2+ transfer to mito-
chondria in HeLa cells [68, 69]. This lack of consensus is
likely due to the method of analysis and cell types used.
There is, however, little doubt that α-Synuclein is present at
MERCS and can lead to dysfunction of the ER or
mitochondria in PD.
Secondly, familial linked PD genes have also been
associated with MERCS. As described previously, the PD-
related protein DJ-1 has been shown to interact with
VDAC, GRP75 and IP3R in a tetramer complex, and is
thought to facilitate Ca2+ homoeostasis, as well as acting as
a functional tether. Ablation of DJ-1 decreases MERCS
association and alters Ca2+ handling, which can be rescued
with WT but not PD-related mutant DJ-1 [5, 6]. Further-
more, both PINK1 and Parkin, two genes mutated in
autosomal recessive PD, acting together to regulate MQC
mechanisms, have been found to localise to MERCS under
mitophagy induction [70]. Induced pluripotent stem cell-
derived dopaminergic neurones show Parkin-dependent
uncoupling of the ER and mitochondria [46]. PINK1
interacts with BECN1, a key component of the class III
phosphatidylinositol 3-kinase complex required for ome-
gosome generation, and localises at MERCS [70]. Over-
expression of Parkin was shown to significantly increase
MERCS in Hela cells, which correlates with enhanced Ca2+
signalling and ATP production [71]. However, reports have
been conflicting, as PARK2- knockout mice and patient
cells showed an increase in the proximity of the ER and
mitochondria and altered Ca2+ flux [72], a result that was
supported in Drosophila models [73]. More recently,
however, loss of Parkin in human fibroblasts resulted in a
decrease in MERCS [74]. These data demonstrate a clear
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role for PINK1 and Parkin in MERCS, but the exact details
are yet to be understood.
Many PINK1- and Parkin-associated proteins have also
been implicated in MERCS, including MFN2 and Miro.
MFN2 (a key tether in MERCS) can be phosphoubiquiti-
nated in a PINK1-/Parkin- dependent manner under induc-
tion of mitophagy, and degraded, resulting in an uncoupling
of the ER from the mitochondria [46]. This was supported
by studies in Drosophila and human fibroblasts, where loss
of Parkin or ubiquitination-preventing mutations in MFN2,
reduced MERCS, implying that PINK1/Parkin can regulate
MERCS through MFN2 [74]. Miro, a target for PINK1/
Parkin in mitochondrial transport along microtubules, has
also been linked with MERCS [75, 76]. Previously, Gem1
(the yeast homologue of Miro) was shown to be a regulator
of the ERMES complex, a known MERCS tether in yeast
[77]. However, Miro has also been reported to have func-
tions outside of mitochondrial dynamics, including reg-
ulating Ca2+ transport through MERCS [78]. A more direct
link has recently been established as two studies identified
Fig. 3 Mitochondrial ER contact sites in neurodegeneration. a AD:
amyloid precursor protein (APP), along with its metabolites, and β-
and γ-secretase enzymes are found in MERCS. The APP is first
cleaved by β-secretase and then γ-secretase to release Aβ. Aβ has been
shown to alter lipid metabolism at MERCS. b ALS: TDP-43 and FUS
in the cytoplasm activate GSK3β by dephosphorylating it at cysteine 9.
GSK3β can then disrupt VAPB and PTPIP51 binding, uncoupling the
ER from the mitochondria and altering Ca2+ signalling. Sig-1R can
bind IP3R, stabilising it in the membrane, while loss of Sig-1R can
result in ALS-like symptoms in mice and uncoupling of MERCS. c
PD: WT or mutated α-Synuclein interacts with VAPB altering its
binding to PTPIP51, disrupting MERCS and Ca2+ signalling. Miro is
present in MERCS and can disrupt Ca2+ signalling and autophagy.
PINK1 and Parkin, under mitophagy induction, have been shown to
localise to MERCS and also impact on Ca2+ signalling and to promote
the phosphoubiquitination of MFN2, resulting in its degradation and
the uncoupling of the mitochondria from the ER. PINK1 and Miro
have also been associated with altered mitophagy as PINK1 interacts
with BECN1. Key autophagy genes (e.g., ATG14L and ATG5) are also
present in MERCS and impact on mitophagy, a pathway
dysregulated in PD.
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novel mutations in RHOT1, the gene that encodes Miro, in
PD patients. All four novel RHOT1 mutations showed
attenuated Ca2+ handling, autophagy and a decrease in
MERCS in patient-derived fibroblasts [79, 80]. Thus, Miro
can influence MERCS, and may lead to dysfunctional ER or
mitochondria in PD (Fig. 3c).
Amyotrophic lateral sclerosis
ALS is a fatal neurodegenerative disease. Familial forms of
ALS account for 10% of all cases with mutations in SOD1,
C9ORF72, FUS and TARDBP occurring most frequently
[81]. Many of these ALS-related genes and others, such as
VAPB, have been associated with altered signalling at
MERCS. Specifically, mutations in VAPB cause an
autosomal-dominant form of ALS and increase the affinity to
its binding partner PTPIP51. This was shown to correlate
with increased Ca2+ transfer into the mitochondria [12].
Furthermore, it has been demonstrated that both WT TDP-43,
ALS- related TDP-43 and FUS expression perturbs MERCS,
which can disturb VAPB–PTPIP51 binding through glyco-
gen synthase kinase 3β (GSK3β) regulation [13, 14], causing
impairment of Ca2+ uptake into the mitochondria and ATP
production [13, 14]. Other studies have linked Sig-1R (an ER
protein that facilitates Ca2+ transfer by binding IP3R in
MERCS) to familial ALS [82] as loss of Sig-1R can uncouple
ER from the mitochondria [83]. Mouse models have sup-
ported this with Sig-1R null mice displaying features of ALS,
while treatment with Sig-1R agonists was beneficial in some
ALS models [83, 84]. Furthermore, disruption of Sig-1R in
SOD1 G85R mice accelerated disease onset while also dis-
rupting MERCS integrity [85]. These data suggest a link
between MERCS and ALS (Fig. 3b).
Functional genetic screens
Functional genomics link gene sequence to function and
have been key in understanding molecular mechanisms of
disease. Combined with genetic screening approaches,
functional genomics is a powerful tool. The introduction of
RNAi and CRISPR/Cas9 has revolutionised genetic
screening due to ease of use, high efficiency, reliability and
cost-effectiveness [86, 87]. Here we will discuss how these
tools may be used to elucidate the role of MERCS in
neurodegenerative diseases.
RNAI vs CRISPR/Cas9
For the last decade, RNAi has been the principal approach for
functional genomic screening. RNAi is a conserved endo-
genous pathway that uses the ribonuclease DICER to cut
double-stranded RNA into small-interfering RNA (siRNA).
The siRNA utilises base complementation in conjunction
with RNA-induced silencing complex (RISC) to degrade
mRNA, reducing protein levels [88]. Artificially, siRNA can
be designed to target any mRNA sequence for any gene of
interest (GOI), making it quick to develop a range of RNAi
libraries (Fig. 4) [82]. More recently CRISPR (clustered
regularly interspaced short palindromic repeat) in combina-
tion with Cas9, an RNA-guided endonuclease [89, 90], has
been used to conduct highly specific genome editing in
mammalian cells [91, 92]. CRIPSR/Cas9 uses guide RNA
(gRNA) to target Cas9 to a specific region of the genome.
Once Cas9 induces double-strand breaks in DNA backbone,
this can be repaired by two main DNA repair pathways: non-
homologous end joining (NHEJ) or homologous recombi-
nation. NHEJ is error prone and results in insertion and/or
deletion (INDELS) in the DNA, shifting the reading frame, to
produce premature stop codons [87]. The major difference
between RNAi and CRISPR/Cas9 is that RNAi produces
knockdown (KD) of the GOI, while CRISPR/Cas9 results in
knockout (KO). While incomplete KD may cause experi-
mental issues, complete KO may be detrimental to cell sur-
vival [93]. Furthermore, siRNAs have reduced base
complementarity and are prone to more off- target effects
than the CRIPSR/Cas9 system [94–96]. CRISPR/Cas9 does
have its disadvantages requiring both gRNA and Cas9 to
conduct editing, making it more time consuming than siRNA,
and the gRNAs cannot be targeted anywhere as they have to
include a protospacer-adjacent motif (PAM) site. However,
these are numerous within a genome and this is rarely a
limiting factor. Overall, the benefits of CRISPR/Cas9 out-
weigh the disadvantages, and now CRISPR/Cas9 systems are
used routinely in functional genomic studies and HTS.
Screening strategies
Two principal screening strategies are used: arrayed and
pooled (Fig. 5). In an arrayed format, reagents are arranged in
multiwell plates with cell targeting of gRNAs or siRNAs
occurring in individual wells. Each step of an arrayed screen
requires a multiwell approach, meaning it can be expensive
and labour intensive, often requiring specialised automated
equipment [86, 87]. The readout from an arrayed screen can
vary and is often related to a phenotype of interest, with
common readouts involving fluorescence [97] and high-
content image analysis [98]. Pooled screens, however, com-
bine reagents in one complex mixture and are conducted on a
single pool of cells. To prevent multiple gRNAs entering a
cell, a low ratio of virus to host cells is used (termed “mul-
tiplicity of infection” (MOI)). Further selection is often
required with pooled screens to select for a phenotype of
interest, for example, treatment with a specific drug or disease
mutation that can be compared to an unselected control pool.
The readout for pooled screens is DNA sequencing, which
ER-mitochondria contact sites in neurodegeneration: genetic screening approaches to investigate novel. . . 1811
reveals the enriched or depleted gRNAs in the cell popula-
tion. Confirmation can be achieved when multiple gRNAs for
the same gene are enriched. Pooled screens are quicker,
cheaper and less labour intensive than arrayed screens.
However, which screening strategy to use depends on a range
of factors, including the phenotype of interest and the read-
outs available, the size of the screen (whole genome vs
druggable/subset) and the cost and efficiency of targeting.
Studying mitochondria-ER contact sites
Owing to its small size and high complexity, studying MERCS
is difficult, but recent technological advances can be coupled
with HTS and offer new opportunities for investigation.
Electron microscopy (EM) and super-resolution
microscopy techniques
EM is the gold standard for visualising MERCS as it can
resolve the close apposition of the ER and mitochondria
membranes (10–30 nm); however, EM requires that samples
must be fixed and processed, making it difficult to collect
multiple images and thus inappropriate for HTS. Super-
resolution techniques have also been used to visualise
MERCS, including stimulated emission depletion (STED),
photo-activation localisation microscopy (PALM), sto-
chastic optical reconstruction microscopy (STORM) and
structural illumination microscopy (SIM) [99–103]. How-
ever, super-resolution techniques are also inappropriate for
HTS. PALM and STORM collate many images and lead to
Fig. 4 Mechanisms for RNAi and CRISPR/Cas9 gene silencing
techniques. In RNAi knockdown, the presence of double-stranded
RNA (dsRNA), microRNA (miRNA) and short-hairpin RNA (shRNA)
in the cell initiates recruitment of the ribonuclease DICER. DICER
cuts dsRNA into shorter fragments called small-interfering RNA
(siRNA). Argonaut is a key component of the RNA-induced silencing
complex (RISC) that can bind non-coding RNAs, including siRNAs,
and recruit the remaining RISC complex components. The RISC
complex identifies mRNA of interest, via complimentary base pairing,
and cleaves it, inhibiting translation of that protein resulting in a
knockdown. The CRISPR/Cas9 system utilises the adaptive immune
response of bacteria to conduct genome editing. Both Cas9 endonu-
clease, as a vector or protein, and gRNAs are required for this process.
gRNAs (aka sgRNAs) are short synthetic RNA sequences composed
of a tracrRNA, a scaffold sequence necessary to bind Cas9, and
crisprRNA (crRNA) (a user-defined 20-bp nucleotide sequence com-
plementary to the gene of interest (GOI)). Through complementary
base pairing of the crRNA, the Cas9 is directed to specific genomic
locations where it creates double-stranded breaks (DSB). Two prin-
cipal mechanisms repair DSB: non-homologous end joining (NHEJ)
and homologous recombination (HR). NHEJ is error prone and can
result in insertions and/or deletions (INDELS) in the genome, causing
frameshift mutations and leading to premature stop codons and gene
knockout. The HR pathway uses template DNA and DNA synthesis
machinery to repair the DNA without error, and can be utilised to
incorporate point mutations or other genes (knock-ins).
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low temporal resolution, while SIM and STED require
specialised, expensive equipment that is not yet automated.
These techniques also require a range of fixation or
mounting processes, making them difficult to conduct on a
large number of samples.
Proximity ligation assay
A highly sensitive approach, termed in situ Proximity
Ligation Assay (PLA), has been used to investigate
endogenous protein interactions [104] and optimised to
study MERCS [105]. This is a probe-based system where
the endogenous proteins of interest are targeted by primary
antibodies, then by specialised secondary antibodies fused
to oligonucleotides. If the two endogenous proteins are in
close proximity, then, on the addition of a third oligonu-
cleotide, there is complementary base paring and the for-
mation of circular DNA. The circular DNA can undergo
rolling DNA replication creating many repeats. This can be
visualised using complementary fluorophore-labelled
Fig. 5 Workflow for pooled and arrayed screening approaches.
Pooled screening requires the gRNA library and Cas9 to be delivered
into cells within a single vessel (using a low MOI viral transduction to
maintain a 1:1 ratio of gRNA to cells). The cells then undergo
selection for transduced cells and further selection for the phenotype of
interest. For example, mean fluorescence intensity (MFI) where the top
and bottom 25% are examined for survival. The output for a pooled
screen comes from deep sequencing of the genomic DNA from control
vs treated samples. Statistical analysis of gRNAs that are enriched or
depleted is conducted. Arrayed screens can be conducted with a wider
range of silencing techniques, including CRISPR/Cas9 or RNAi. This
is because the final readout comes from phenotypic analysis, rather
than deep sequencing of genomic DNA. Individual gRNAs and siR-
NAs are delivered (by transduction or transfection) to cells in specific
wells of a 96-well plate (eliminating the possibility that more than one
gRNA or si9RNA could be delivered per cell). The transfected cells
remain in an arrayed format for phenotype analysis, and statistical
analysis in which phenotypes of interest can be matched with gRNA/
siRNA by their position in the plate.
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probes (Fig. 6a) [106]. This technique is highly specific as it
uses duel recognition from primary and secondary anti-
bodies, it can be conducted on multiple conditions as the
readout is fluorescence and specialised imaging equipment
is not needed [105]. However, false detection rates are high;
therefore, isotope antibody controls are routinely used to
detect background fluorescence from potentially unspecific
primary antibodies [107, 108]. In PLA, the detection of
fluorescence without the need for fluorescent proteins
decreases the potential for artefacts, meaning readouts are
easily measured in either pooled or arrayed screens. How-
ever, the sample preparation requires fixation and multiple
incubation steps, making it highly costly and labour inten-
sive. Furthermore, the range of detection for PLA is
between 40 and 60 nm, greater than the size of most
MERCS, hence, it is showing protein proximity rather than
protein–protein interactions; however, this is greater than
the resolution gained from a traditional fluorescence
microscope and simple co-localisation analysis [109]. Thus,
while the practicality of PLA in HTS is limited, it could be
suitable for hit validation.
Split fluorescence reporters of contacts
Like PLA, other methods that rely on construct proximity
are split FP systems, including biomolecular fluorescence
complementation (BiFC), double-dimerising GFP (ddGFP),
fluorescence resonance emission transfer (FRET) and bio-
luminescence resonance emission transfer (BRET).
Biomolecular fluorescence complementation (BiFC)
Typically, in BiFC, a FP is split into two non-fluorescent
fragments that are fused to the proteins of interest. With
regard to MERCS, they are tethered to either resident ER or
mitochondrial proteins. If the two membranes come into
close proximity, then the two complementary fragments of
the FP will reassemble, restoring the fluorescence of the
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chromophore [110]. A range of BiFC constructs using dif-
ferent FP have been developed, including split mVenus,
spGFP1–10/spGFP11 and dsRFP [111, 112]. These have
been successfully used to investigate novel proteins asso-
ciated with MERCS [113–115]. The simplicity of the
fluorescence readout makes BiFC ideal for HTS and has
been used previously in large-scale protein–protein inter-
action studies [116–118]. A major disadvantage of BiFC
technique is that it requires folding of two FP fragments that
are thermodynamically stable and adverse to unfolding
[119]. This may limit screening investigating increases in
MERCS. Furthermore, BiFC systems are prone to sponta-
neous assembly that may alter basal stress levels in the cell
(Fig. 6b) [120].
Double-dimerising green fluorescent protein (ddGFP)
The ddGFP system has also been used to investigate
MERCS and involves the reversible binding of two non-
fluorescent, “dark”, ddGFP monomers, ddGFPa and
ddGFPb, to produce a fluorescent heterodimer. ddGFPa is
mutated (I11L and S14A and K163G) such that the chro-
mophore is destabilised and quenched, while ddGFPb
completely lacks a chromophore. When ddGFPa hetero-
dimerises with ddGFPb, complementation occurs and a
fluorescent heterodimeric complex is formed [121, 122].
This system, like BiFC, can be fused to a variety of proteins
of interest and has been used to study protein–protein
interactions (Fig. 6c) [11, 121]. The advantages of this
method are similar to BiFC, namely ease of use, a simple
readout and low labour intensity with the added advantage
of requiring no protein folding in order to obtain the
fluorescent readout. However, ddGFP systems tend to have
intrinsically low fluorescence that may limit the utility of
these constructs in screening as it would limit the assay
range. One solution would be the use of an adapted split FP
system such as splitFAST. SplitFAST relies on the binding
of a 14-kDa protein Fluorescence-activating and Absorption
Shifting Tag (FAST) to a HydroxyBenzylidene Rhodanine
(HBR) analogue. HBR analogues are weakly fluorescent in
solution, but the binding of FAST precipitates them and
increases their fluorescence in a reversible manner [123].
SplitFAST alleviates the problem of reversibility and
spontaneous assembly of BiFC system and low fluorescence
output of ddGFP system while maintaining the easy readout
and low labour intensity of split FP systems, which make
them ideal for HTS of either type (Fig. 6d).
FRET- and BRET-based systems
FRET is a collision-free, but distance-dependent, process
that involves the transfer of energy from one excited donor
fluorophore to a suitable acceptor fluorophore [124]. FRET
fluorophore pairs have been fused to resident ER and
mitochondrial proteins and used as an interaction-free way
to detect MERCS [11, 74]. A major advantage over BiFC is
there is no requirement for protein folding and so it is
thought to be reversible. Furthermore, FRET is intrinsically
sensitive to molecular distance, as energy transfer is
proportional to the distance between the two fluorophores,
thus giving a fluorescence readout for the distance
between the two membranes (Fig. 6e) [11, 74, 124].
Fig. 6 Fluorescence-based techniques to visualise MERCS. a PLA:
the sample is fixed and incubated with primary antibodies targeting
proteins in MERCS (usually MERCS tethers) and a modified sec-
ondary antibody (which is attached to an oligonucleotide strand). If the
two proteins are in close proximity, as they are in MERCS, the
addition of a third oligonucleotide results in complementary base
pairing between the three oligonucleotides and the formation of cir-
cular DNA. The circular DNA can undergo rolling circle amplification,
creating a long strand of DNA and multiple copies of the circular
DNA. Fluorescent probes are designed to be complementary to a
sequencing within the circular DNA. The probes hybridise in multiple
regions, allowing the visualisation of the fluorescent signal and
MERCS. b BiFC also utilises proximity to visualise MERCS. Two
non-fluorescence fragments of a fluorescence protein, commonly GFP
or Venus, are fused to transmembrane domains, or whole proteins,
found in the ER or mitochondrial membrane. If MERCS does not form
the BiFc, constructs remain separate and do not fluoresce, but when
MERCS forms, the ER and mitochondria membrane come into close
proximity bringing with them the two non-fluorescent fragments,
allowing them refold into whole GFP or Venus protein whose fluor-
escence can be visualised and measured. c Similarly, the ddGFP
system is fused to protein fragments or whole proteins found in ER and
mitochondria membrane; however, each protein is fused to non-
fluorescence ddGFP monomers. One monomer contains a chromo-
phore that is destabilised and quenched, while the other completely
lacks a chromophore. When MERCS forms, these ddGFP monomers
come into close proximity, heterodimerise and complement each other,
allowing fluorescent detection. As there is no protein folding, this
process is reversible. d splitFAST utilises the 14- kda protein (FAST),
which is split into N- and C-terminal fragments. These fragments can
be attached to two interacting proteins or membrane fragments of a
protein. For the study of MERCS, these interacting proteins would be
in the ER or mitochondrial membrane. When MERCS forms, the N
and C fragments combine, and upon the addition of HBR, they
fluoresce allowing visualisation of MERCS. This is reversible, as HBR
can be added or removed, but the FAST protein can also dissociate
when the ER and mitochondria membrane are not in close proximity. e
FRET: a FRET donor (CFP) and FRET acceptor (YFP) are fused to
resident ER or mitochondrial proteins or transmembrane protein
fragments. When ER or mitochondrial membranes are not in close
proximity, a light source illuminates the CFP donor but the YFP
acceptor is not close enough for FRET to occur and so blue light
emitted. When MERCS forms, the FRET donor (CFP) and acceptor
(YFP) are in close proximity, so FRET can occur, and blue light is
transferred to YFP and yellow fluorescence is emitted. This is rever-
sible as no protein folding or contact occurs between FRET pairs, f
BRET also employs FRET to visualise MERCS; however, rather than
CFP, the resident ER, mitochondria protein or transmembrane frag-
ments are fused to a luciferase enzyme that acts as a light source.
When MERCS forms, the luciferase enzyme and FRET acceptor are in
close proximity, and so energy transfer can occur from the luciferase
enzyme and YFP, which is emitted as yellow florescence. This is
reversible as no protein folding occurs.
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Rapamycin-inducible FRET-based probes are an example
of a successful FRET tool used to visualise MERCS [125].
The addition of rapamycin allows maximal energy transfer
between FRET pairs, enabling quantitative measurements
of contact distance; however, equimolar concentrations of
the FRET pairs are required as FRET is affected by the
relative amount of each florophore [125]. This was skilfully
overcome by transfection of one plasmid containing both
acceptor and donor constructs separated by TAV2a
sequence (which self-cleaves), achieving equal expression
of both FRET pairs, and has been used in conjunction with
rapamycin to investigate potential MERCS proteins,
including MFN2 and Parkin [11, 74]. In theory, FRET
probes would be ideal for HTS; however, in practice,
FRET-based assays have a low signal-to-noise ratio, limit-
ing reliability of the FRET values and, due to the need for
an external light source, are prone to photobleaching. BRET
is a variant of FRET, which does not require an external
light source, as the donor fluorophore consists of a luci-
ferase enzyme. The luciferase enzyme oxidises the substrate
bioluminophore providing light for energy transfer to the
acceptor [126]. Internal illumination has two main benefits:
firstly, it reduces phototoxicity and bleaching, thereby
decreasing noise previously seen with FRET. Secondly, the
orientation of acceptor and donor fluorophores is less
essential, making it easier for energy transfer to occur
(Fig. 6f). Together, this makes BRET robust and more
sensitive, which is beneficial in either pooled or arrayed
HTS; however, only one such probe, Mitochondria-ER
Length Indicator Nanosensor (MERLIN) developed by the
Garcia-Saez lab, is currently fit for purpose [127].
Calcium-based sensors
Functional readouts, such as Ca2+ flux, could allow for
different avenues of MERCS investigation. Many tools can
be used to visualise intracellular Ca2+, including biolumi-
nescent proteins such as aequorin, which upon binding of
Ca2v, undergo a conformational change, oxidation of coe-
lenterazine and emission of a photon at 470 nm, chemical
Ca2+ indicators and dyes that change their emitted fluor-
escence when Ca2+ is bound or genetically encoded Ca2+
indicators (GECI), which contain Ca2+ binding protein
Calmodulin, which, with the binding of Ca2+, changes the
fluorophore environment resulting in fluorescence128. Pre-
viously, the combination of cytosolic (Fluro4) and mito-
chondria (Rhod2) fluorescent dyes has been used to
investigate Ca2+ flux and functionality of MERCS in vitro
[12–14, 128]. Single-fluorophore GECI, GCaMP, targeted
to mitochondria or ER, has also been used successfully
in vitro and in vivo [103, 129]. These methods are simple,
have a range of fluorophores and have a fluorescence
readout; however, chemical Ca2+ indicators require dye
loading, increasing workload. Aequorin, however, has a
high signal-to-noise ratio, a wide dynamic range and does
not require an external illumination avoiding phototoxicity,
but the recharge process, via coelentrazine, is slow and thus
makes it suboptimal for HTS [130]. GECIs have previously
been used with flow cytometry in a high-throughput manner
and can be genetically targeted to various membranes
within the cells [128, 130]. Furthermore, previous short-
comings, such as decreased sensitivity, small dynamic range
compared to dyes [131] and cytotoxic accumulation of
GECIs in the nucleus [132] were rectified in this study
[132]. Thus, GECIs have the potential to be used as a tool in
HTS of MERCS, more specifically in pooled CRISPR
screening due to their ease of use with flow cytometry
[133, 134].
Conclusions
Overall, MERCS has been implicated in a range of neuro-
degenerative diseases, but many questions still remain
unanswered. A range of different tools have been developed
to study MERCS in a range of circumstances. The
microscopy-based techniques, such as EM, SEM, SIM and
STORM, are remarkable in their ability to visualise
MERCS on the nm scale, but require specialised equipment
and can only be conducted on a small number of samples;
therefore, they are not suitable for screening. Both PLA and
split FP use fluorescence as a readout and the proximity of
membrane-bound ER and mitochondrial proteins to visua-
lise MERCS. A downside of PLA is that it requires fixation
and has multiple incubation steps, meaning it cannot be
used as HTS but would likely be useful in the validation of
hits. Unlike PLA, split FP can easily be conducted on a
large scale as it has limited sample or data processing,
specialised equipment is not needed and stable cell lines can
be engineered, which dramatically reduces cost and labour.
The range of split FP comes with its own advantages and
disadvantages: BiFC has the simplest readout, clearest sig-
nal and least noise-associated analysis, unlike ddGFP,
FRET or BRET. The advantage of FRET/BRET probes is
that they do not self-assemble and are reversible, as they do
not require protein folding. BRET also has reduced photo-
toxicity and bleaching, thereby decreasing noise previously
seen with FRET. GECIs may also be suitable for investi-
gating MERCs, these sensors do not rely on proximity of
either the mitochondria or ER, but the influx of Ca2+ into
the mitochondria from the ER. However, MERCS has a
variety of functions, not only Ca2+ homoeostasis, and this
approach may exclude potential regulators of other func-
tional subtypes of MERCS2.
Overall, BRET probes would make a good choice for
HTS of MERCS, but screening using the other FP systems
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(specifically splitFAST) would also allow for rapid dis-
covery of novel proteins involved with MERCS regulation
in neurodegenerative disease with relative ease. Further-
more, GECIs have been shown to be successful in high-
throughput screening to investigating Ca2++ flux and so are
also suitable for investigating MERCS. The combination of
both proximity-based and functional (Ca2+ indicators)
screening approaches would be highly beneficial in under-
standing both the physical and functional role of MERCS in
neurodegenerative diseases.
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